These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31390856)

  • 1. The Impact of Impulsivity on Quality of Life in Early Drug-Naïve Parkinson's Disease Patients.
    Ryu DW; Kim JS; Yoo SW; Oh YS; Lee KS
    J Mov Disord; 2019 Sep; 12(3):172-176. PubMed ID: 31390856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Italian version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS) in an Italian Parkinson's disease cohort.
    Maggi G; Vitale C; Giacobbe C; Barone A; Mastromarino C; Iannotta F; Amboni M; Weintraub D; Santangelo G
    Neurol Sci; 2024 Jul; 45(7):3153-3161. PubMed ID: 38231374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender Differences in Impulse Control Disorders and Related Behaviors in Patients with Parkinson's Disease and its Impact on Quality of Life.
    Paul BS; Singh G; Bansal N; Singh G; Paul G
    Ann Indian Acad Neurol; 2020; 23(5):632-637. PubMed ID: 33623263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Korean Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease Rating Scale.
    Choi JH; Lee JY; Cho JW; Ko SB; Ahn TB; Kim SJ; Cheon SM; Kim JS; Kim YJ; Ma HI; Baik JS; Lee PH; Chung SJ; Kim JM; Song IU; Kim HJ; Sung YH; Kwon DY; Lee JH; Kim JY; Kim JS; Yun JY; Kim HJ; Hong JY; Kim MJ; Youn J; Kim JS; Oh ES; Yang HJ; Yoon WT; You S; Kwon KY; Park HE; Lee SY; Kim Y; Kim HT; Park MY
    J Clin Neurol; 2020 Apr; 16(2):245-253. PubMed ID: 32319241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS).
    Marques A; Vidal T; Pereira B; Benchetrit E; Socha J; Pineau F; Elbaz A; Artaud F; Mangone G; You H; Cormier F; Galitstky M; Pomies E; Rascol O; Derkinderen P; Weintraub D; Corvol JC; Durif F;
    Parkinsonism Relat Disord; 2019 Jun; 63():117-123. PubMed ID: 30862454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?
    Toś M; Grażyńska A; Antoniuk S; Siuda J
    Brain Sci; 2024 Feb; 14(2):. PubMed ID: 38391755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Chinese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease.
    Xu T; Cao L; Long W; Zhao G
    Front Neurol; 2021; 12():731552. PubMed ID: 34950097
    [No Abstract]   [Full Text] [Related]  

  • 8. Impulse control disorders and related behaviours (ICD-RBs) in Parkinson's disease patients: Assessment using "Questionnaire for impulsive-compulsive disorders in Parkinson's disease" (QUIP).
    Sharma A; Goyal V; Behari M; Srivastva A; Shukla G; Vibha D
    Ann Indian Acad Neurol; 2015; 18(1):49-59. PubMed ID: 25745311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?
    Houeto JL; Magnard R; Dalley JW; Belin D; Carnicella S
    Front Psychiatry; 2016; 7():91. PubMed ID: 27303314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications.
    Hernandez-Con P; Lin I; Mamikonyan E; Deeb W; Feldman R; Althouse A; Barmore R; Eisinger RS; Spindler M; Okun MS; Weintraub D; Chahine LM
    Mov Disord Clin Pract; 2023 Jun; 10(6):903-913. PubMed ID: 37332637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.
    Laurencin C; Timestit N; Marques A; Duchez DD; Giordana C; Meoni S; Huddlestone M; Danaila T; Anheim M; Klinger H; Vidal T; Fatisson M; Caire C; Nourredine M; Boulinguez P; Dhelens C; Ballanger B; Prange S; Bin S; Thobois S
    J Neurol; 2023 Oct; 270(10):4851-4859. PubMed ID: 37338615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impulse control and related disorders in Mexican Parkinson's disease patients.
    Rodríguez-Violante M; González-Latapi P; Cervantes-Arriaga A; Camacho-Ordoñez A; Weintraub D
    Parkinsonism Relat Disord; 2014 Aug; 20(8):907-10. PubMed ID: 24935236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical and genetic study of impulsive-compulsive disorders in patients with Parkinson's disease].
    Shipilova NN; Titova NV; Kokaeva ZG; Fedosova AS; Klimov EA; Katunina EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10):4-9. PubMed ID: 30499488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease (QUIP) and the QUIP-rating scale in a German speaking sample.
    Probst CC; Winter LM; Möller B; Weber H; Weintraub D; Witt K; Deuschl G; Katzenschlager R; van Eimeren T
    J Neurol; 2014 May; 261(5):936-42. PubMed ID: 24609972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trait Impulsivity as a Feature of Parkinson's Disease Treatment and Progression.
    Spencer H; Anderton RS
    Parkinsons Dis; 2024; 2024():8770997. PubMed ID: 38766569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control.
    Hammes J; Theis H; Giehl K; Hoenig MC; Greuel A; Tittgemeyer M; Timmermann L; Fink GR; Drzezga A; Eggers C; van Eimeren T
    Brain; 2019 Mar; 142(3):733-743. PubMed ID: 30753324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric morbidity, cognitive dysfunction and quality of life in drug-naive patients with Parkinson's disease: A comparative study.
    Dhar SS; Jeenger J; Singroha V; Sharma M; Mathur DM
    Ind Psychiatry J; 2019; 28(1):13-18. PubMed ID: 31879441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients.
    Phu AL; Xu Z; Brakoulias V; Mahant N; Fung VS; Moore GD; Martin A; Starcevic V; Krause M
    J Clin Neurosci; 2014 Jan; 21(1):63-6. PubMed ID: 24035421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.